AstraZeneca has said it would stop selling the blockbuster heartburn medicine Nexium, which was pulled from the market in August, after it had been linked to a heart attack.
The pharmaceutical giant has been approached by some drug makers to sell its generic version of Nexium, which treats a painful type of GERD known as peptic ulcer disease, but will be out of stock in the wake of the decision.
Last year, the company said it would not sell the drug for more than three years, despite reports that it could be linked to a similar condition.
The firm said it is working to develop a generic version of the drug and would make a decision on whether to pull the drug from the market.
Nexium, which was developed by AstraZeneca and marketed as Prilosec, is an effective medicine that treats a variety of gastrointestinal disorders. It is approved for use in the UK and other countries.
The drug was first approved in 2002 as an over-the-counter medicine. The company said that in May 2004, it became aware of reports that it was being sold by AstraZeneca to other drug makers.
The company said that its drug was the first approved drug for a serious condition in the United States.
In August, it announced it would stop selling the drug and the company would sell its generic version to its U. S. sales partner GlaxoSmithKline.
AstraZeneca said it is committed to meeting the company's goals and will continue to work to achieve them, as well as to work with other pharmaceutical companies.
The company was not immediately available for comment on the results of the second clinical trial, which was conducted by the US Food and Drug Administration to evaluate Nexium's safety and efficacy, though it was expected to return to the trial later in the year.
The trial, which involved 1,050 participants, had found that the drug improved symptoms of gastroesophageal reflux disease.
The results of the trial were expected to be published in the January 2005 issue ofThe New England Journal of Medicine.
AstraZeneca:“We are very pleased to be working with GlaxoSmithKline and the other companies in the study to get the results of our Phase 2 clinical trial to reflect the results of the current Phase 3 trial," AstraZeneca said in a statement.
The company said that it had no plans to change its marketing strategies, which are aimed at getting people to eat the best diet they can, in order to keep the patient's health under control.
However, it added that it was working with the companies to get the results of the trial to reflect the results of the second clinical trial.
“We will continue to work with GlaxoSmithKline and other companies in the trial to make our results available to patients,” said Dr. John R. Anderson, an AstraZeneca spokesman.
The firm said that it had no plans to change its marketing strategies, which are aimed at getting people to eat the best diet they can, in order to keep the patient's health under control.
AstraZeneca also said it would not sell Nexium to other drug makers because of concerns about the company’s safety.
The company said that it was committed to meeting the company's goals and is working with other pharmaceutical companies to achieve them. It will continue to work with other drug companies to achieve the goals and work with other pharmaceutical companies to achieve the results they have.
AstraZeneca is based in Cambridge, England, and is one of the largest pharmaceutical companies in the world. It has a research and development center in the UK.
In September, AstraZeneca said it would stop selling Nexium to its patients, after it was linked to a heart attack.
AstraZeneca said that its decision to sell Nexium to its patients was based on a “concrete need” and would not affect its future plans to make a generic version of the drug available to patients.
“We are committed to meeting the company’s goals and will continue to work to achieve them, as well as to work with other pharmaceutical companies to achieve the results we have today.
“In addition, we have no plans to change our marketing strategies, which are aimed at getting people to eat the best diet they can, in order to keep the patient’s health under control.
The Food and Drug Administration (FDA) is advising consumers not to purchase any of the product, including the generic version of Nexium, for more than two years after a positive test indicated it is a safe and effective treatment for congestive heart failure.
Nexium, a prescription medication used to treat heart failure, is available without a prescription from several drug companies, including AstraZeneca and Merck & Co.
According to a press release by the agency, consumers are advised to consult a healthcare professional for any concerns regarding the safety of Nexium and related products.
In addition, the agency notes that the FDA has also noted concerns regarding the safety of certain drugs used to treat high blood pressure (hypertension), as well as certain medications used to treat certain types of fungal infections such as toenail fungus.
The FDA recommends consumers consult with a healthcare professional before taking any new prescription or over-the-counter (OTC) medication.
This press release notes that consumers are advised to be well-informed about the potential risks and benefits of these products and the potential adverse reactions associated with their use.
“Consumers should be aware of the potential adverse reactions associated with Nexium use, and take appropriate actions to minimize these risks,” said Michael E. Schafer, Ph. D., Senior Vice President, Health and Medical Affairs at AstraZeneca.
According to the press release, consumers are encouraged to report negative side effects or adverse reactions to the agency by calling 1-866-234-2345.
For more information about Nexium, please visit.
For further information about Nexium, visit.For more information about Nexium, visit.
References:
FDAApproved on June 4, 2024, byDr. David M. Rosenblum
Medscape.comis a news and entertainment site, based in Tempe, Arizona, that caters to a broad international audience. It is among the largest and most influential news outlets in the United States. It is featured in the U. S. and covers the issues that affect the global healthcare market, from COVID-19 to the rise of digital healthcare. It also covers the latest developments in medicine, with a special focus on COVID-19 vaccines and treatments for COVID-19.
The content in this article is exclusive to The Medscape. It may not be reproduced in any form without permission from Medscape.
The Medscape.com blog is a collaboration between Medscape, a global publisher of health-related content, and The Medscape Publishing, a division of The New York Times Company.
Medscape.com was founded in 1868 by a group of American medical doctors and pharmacists. Medscape has its roots in Arizona and has been a pioneer in the field of medical technology for over 35 years. The company is headquartered in Tempe, Arizona, and operates as a news and entertainment news site, medical information section, and health information site. Medscape.com is a part of the Medscape Family of Companies, Inc., which is based in Tempe, Arizona, and operates as a news and entertainment news site, medical information section, and health information section. Medscape.com is a part of The Medscape Family of Companies, Inc., which is based in Tempe, Arizona, and operates as a news and entertainment news site, medical information section, and health information section.
In 2021, the Medscape.com blog was featured in the New York Times, and in March 2024, the company published its.
The Medscape.com blog is based in Tempe, Arizona and is overseen and operated by The Medscape Publishing, Inc.
Medscape.com has been selected by more than 30 medical organizations, including the American College of Cardiology, the American Heart Association, the American Association for the Study of Cardiology, the American Heart Association, and the American College of Physicians.
For more information about Medscape.com, visit.
Medscape.com is a news and entertainment news site, based in Tempe, Arizona, and is featured in the U. and by, and is also a part of The Medscape Family of Companies, Inc., which is based in Tempe, Arizona, and operates as a news and entertainment news site, medical information section, and health information section.
Alternate Name:Pharmapure RX Esomep-EZS
Description:Nexium treats gastroesophageal reflux disease (GERD), esophagitis, and stomach ulcers. The generic version of Nexium is esomeprazole magnesium. For a supply of 30 oral tablets of Nexium Delayed-Release Capsules 40 mg is approximately $287. Take advantage of our LowerMyRx discount to receive a typical Nexium discount of up to 80% off of the retail price at participating pharmacies near you.
Dosage Form:Capsule Delayed Release
Administration Route:By mouth
Drug Class:Gastric Acid Secretion Inhibitor, Gastrointestinal Agent
Generic Available:Yes
Strength:20 MG
Warnings:Tell your doctor if you are pregnant or breastfeeding, or if you have kidney disease, liver disease, lupus, vitamin B12 deficiency, or osteoporosis. This medicine may cause the following problems: Kidney problems, including acute tubulointerstitial nephritisIncreased risk of broken bones in the hip, wrist, or spine (more likely if used several times per day or longer than 1 year)Serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and drug reaction with eosinophilia and systemic symptoms (DRESS)LupusFundic gland polyps (abnormal growth in the upper part of your stomach) This medicine can cause diarrhea. Call your doctor if the diarrhea becomes severe, does not stop, or is bloody. Do not take any medicine to stop diarrhea until you have talked to your doctor. Diarrhea can occur 2 months or more after you stop taking this medicine. Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments. Keep all medicine out of the reach of children. Never share your medicine with anyone. Stomach pain, nausea, vomiting, weight loss, bloody or black stools
Food Warnings:Do not use esomeprazole if you are also using medicines that contain rilpivirine., Some medicines can affect how esomeprazole works. Tell your doctor if you are using any of the following: Atazanavir, cilostazol, diazepam, digoxin, erlotinib, ketoconazole, methotrexate, mycophenolate mofetil, nelfinavir, rifampin, saquinavir, St John's wort, tacrolimus, voriconazoleBlood thinner (including clopidogrel or warfarin)Diuretic (water pill)Iron supplements, This medicine can cause diarrhea. Diarrhea can occur 2 months or more after you stop taking this medicine., Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results., Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments., Keep all medicine out of the reach of children.
InboxStore this medicine at room temperature, protected from light
Nexium Delayed-Release CapsulesNexium (esomeprazole) is used to treat:
Take special care with Nexium Delayed-Release Capsules: These medicines may cause your fluid retention to increase, which can cause symptoms such as: Flushing, muscle pain, headache, tiredness, drowsiness, unusual weakness or feeling of others, and confusion.
Tell your doctor if you have problems getting an erection or if you have asthma or diabetes. Do not take this medicine if you are also taking a diuretic.
The following is a list of drugs that have been prescribed in Mexico for patients who have had heartburn.
These drugs may be used alone or in combination with other drugs to treat a heartburn that is severe enough to require hospitalization. In some cases, the treatment may be withdrawn.
These drugs are used to treat acid-related symptoms such as heartburn and to treat acid reflux.
Some of the drugs prescribed for heartburn in Mexico include the following drugs:
A combination of esomeprazole and omeprazole is used to treat heartburn and to treat acid-related symptoms. The drug is taken twice a day. Nexium is an antacid that works as an antacid for stomach acid. It also helps reduce stomach acid.
A gastroesophageal reflux disease (GERD) medicine is used to treat GERD. It is a medicine that helps to reduce the amount of acid that flows from the stomach. This helps to relieve the symptoms of GERD.
The following drug is used in combination with esomeprazole and omeprazole:
The drug Pepcid is an antacid and works as an antacid for stomach acid.
It is a medicine that helps to relieve the symptoms of GERD. This medicine is also used to treat the symptoms of GERD. In addition to Pepcid, a gastroesophageal reflux disease medicine is used to treat GERD.
The following drug is used in combination with Pepcid:
The following is a list of drugs that have been prescribed in Mexico for patients who have been given a prescription for a heartburn drug.
A combination of esomeprazole and omeprazole is used to treat acid-related symptoms such as heartburn and to treat acid reflux.
In addition to Nexium, a gastroesophageal reflux disease medicine is used to treat GERD.
Stade de France Pharmacy